Entry |
|
Name |
Epoetin alfa (USAN/INN); Epoetin kappa (INN); Epoetin alfa (genetical recombination) (JP18); Epoetin kappa (genetical recombination) [Epoetin alfa biosimilar 1] (JAN); Epoetin alfa-epbx; Epogen (TN); Epoetin alfa BS (TN) |
Product |
|
Formula |
C809H1301N229O240S5
|
Exact mass |
18224.5242
|
Mol weight |
18235.71
|
Sequence |
APPRLICDSR VLERYLLEAK EAENITTGCA EHCSLNENIT VPDTKVNFYA WKRMEVGQQA VEVWQGLALL SEAVLRGQAL LVNSSQPWEP LQLHVDKAVS GLRSLTTLLR ALGAQKEAIS PPDAASAAPL RTITADTFRK LFRVYSNFLR GKLKLYTGEA CRTGD (Disulfide bridge: 7-161, 29-33) |
Type |
Peptide |
Remark |
Therapeutic category: | 3999 |
Product (DG00177): | D03231<JP/US> D03232<JP> |
|
Efficacy |
Anti-anemic, Hematinic, Erythropoietin receptor agonist |
Disease |
Anemia due to chronic kidney disease [DS: H01642] |
Target |
|
Pathway |
hsa04060 | Cytokine-cytokine receptor interaction |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
B BLOOD AND BLOOD FORMING ORGANS
B03 ANTIANEMIC PREPARATIONS
B03X OTHER ANTIANEMIC PREPARATIONS
B03XA Other antianemic preparations
B03XA01 Erythropoietin
D03231 Epoetin alfa (USAN/INN) <JP/US>
USP drug classification [BR:br08302]
Blood Products and Modifiers
Erythropoiesis Promoters
Erythropoiesis-Stimulating Agents
Epoetin Alfa
D03231 Epoetin alfa (USAN/INN)
Therapeutic category of drugs in Japan [BR:br08301]
3 Agents affecting metabolism
39 Other agents affecting metabolism
399 Miscellaneous
3999 Others
D03231 Epoetin alfa (USAN/INN); Epoetin kappa (INN); Epoetin alfa (genetical recombination) (JP18); Epoetin kappa (genetical recombination) [Epoetin alfa biosimilar 1] (JAN)
Target-based classification of drugs [BR:br08310]
Cytokines and receptors
Cytokine receptors
CSF and other factor receptors
EPOR
D03231 Epoetin alfa (USAN/INN) <JP/US>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D03231 Epoetin alfa (genetical recombination)
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D03231
|
Other DBs |
|
LinkDB |
|